Soumendranath Bhakat

May 8, 2024 | biorxiv.org | Soumendranath Bhakat |Ioannis Siokas |Rachel M Covitz |Alexei Degterev

AbstractThe authors have withdrawn their manuscript owing to a conflict of interest. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author, Soumendranath Bhakat. Competing Interest StatementThe authors have declared no competing interest.

Apr 30, 2024 | biorxiv.org | Soumendranath Bhakat |Rachel M Covitz |Alexei Degterev |Ioannis Siokas

AbstractReceptor-interacting protein kinase 2 (RIPK2) regulates key signaling pathways in immune responses and inflammation, making it an intriguing target for treating inflammatory diseases such as inflammatory bowel disease.